Ralf P Brandes Selected Research

N- (2- acetyl- 4,6- dimethylphenyl)- 3- (3,4- dimethylisoxazol- 5- ylsulfamoyl)thiophene- 2- carboxamide

6/2011

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ralf P Brandes Research Topics

Disease

19	Inflammation (Inflammations) 01/2021 - 07/2003
15	Hypoxia (Hypoxemia) 01/2022 - 07/2006
15	Atherosclerosis 01/2021 - 08/2006
14	Hypertension (High Blood Pressure) 01/2022 - 10/2003
11	Pulmonary Hypertension 01/2022 - 07/2006
7	Vascular Diseases (Vascular Disease) 01/2021 - 10/2008
6	Vascular Remodeling 12/2017 - 09/2005
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2015 - 01/2005
5	Myocardial Infarction 01/2020 - 03/2006
5	Ischemia 04/2013 - 11/2007
4	Neoplasms (Cancer) 03/2022 - 01/2018
4	Emphysema 01/2022 - 06/2014
4	Reperfusion Injury 01/2019 - 09/2010
4	Hypertrophy 03/2015 - 09/2010
3	Familial Primary Pulmonary Hypertension 01/2022 - 02/2009
3	Neuralgia (Stump Neuralgia) 01/2021 - 07/2012
3	Aneurysm (Aneurysms) 03/2014 - 10/2011
3	Albuminuria 01/2013 - 08/2010
3	Fibrosis (Cirrhosis) 07/2012 - 09/2007
3	Stroke (Strokes) 07/2012 - 11/2007
2	Heart Diseases (Heart Disease) 01/2021 - 10/2010
2	Neointima 01/2021 - 05/2010
2	Vascular System Injuries 01/2021 - 04/2002
2	Chronic Obstructive Pulmonary Disease (COPD) 07/2020 - 01/2020
2	Sepsis (Septicemia) 01/2019 - 12/2014
2	Atherosclerotic Plaque (Atheroma) 01/2019 - 10/2008
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2018 - 02/2003
2	Aortic Aneurysm (Aneurysm, Aortic) 01/2018 - 12/2013
2	Liver Diseases (Liver Disease) 10/2017 - 07/2012
2	Infections 12/2015 - 07/2003
2	Renovascular Hypertension (Goldblatt Syndrome) 06/2014 - 10/2003
2	Ischemic Stroke 04/2013 - 07/2012
2	Body Weight (Weight, Body) 06/2012 - 06/2011
2	Cardiomegaly (Heart Hypertrophy) 06/2011 - 08/2006
2	Heart Failure 02/2011 - 06/2006
2	Brain Injuries (Brain Injury) 10/2010 - 11/2007
2	Hyperlipidemias (Hyperlipidemia) 10/2008 - 11/2006

Drug/Important Bio-Agent (IBA)

25	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 04/2002
24	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2020 - 04/2003
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
8	Angiotensin IIIBA 12/2013 - 10/2003
7	EnzymesIBA 01/2022 - 07/2003
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 01/2005
7	Epoxide HydrolasesIBA 01/2019 - 04/2005
6	Tamoxifen FDA LinkGeneric 01/2021 - 04/2012
6	Superoxides (Superoxide)IBA 01/2020 - 07/2004
6	MonocrotalineIBA 07/2017 - 02/2009
5	AntioxidantsIBA 02/2018 - 10/2010
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2014 - 02/2003
4	SmokeIBA 01/2022 - 01/2008
4	NADPH Oxidase 4IBA 01/2021 - 10/2017
4	LipidsIBA 01/2019 - 12/2004
3	Transcription Factors (Transcription Factor)IBA 03/2022 - 03/2016
3	Hormones (Hormone)IBA 01/2021 - 09/2014
3	ApolipoproteinsIBA 01/2019 - 12/2013
3	CytokinesIBA 01/2018 - 01/2008
3	Oxygen (Dioxygen)IBA 08/2017 - 01/2005
3	Messenger RNA (mRNA)IBA 12/2014 - 04/2002
3	Oxidoreductases (Dehydrogenase)IBA 03/2014 - 11/2007
3	Protein Isoforms (Isoforms)IBA 04/2013 - 02/2012
3	NADP (NADPH)IBA 07/2012 - 03/2006
2	Pharmaceutical PreparationsIBA 03/2022 - 10/2009
2	Hypoxia-Inducible Factor 1IBA 03/2022 - 09/2014
2	Cysteine (L-Cysteine)FDA Link 01/2022 - 08/2017
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2022 - 01/2020
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2021 - 08/2017
2	NitratesIBA 01/2021 - 08/2008
2	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2021 - 08/2008
2	Long Noncoding RNAIBA 01/2020 - 01/2019
2	LyasesIBA 01/2020 - 01/2019
2	CystathionineIBA 01/2020 - 01/2019
2	Toll-Like Receptor 4IBA 01/2019 - 10/2017
2	BiglycanIBA 01/2019 - 01/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 03/2014
2	Sulfhydryl Compounds (Thiols)IBA 12/2017 - 08/2014
2	LipopolysaccharidesIBA 10/2017 - 07/2013
2	CalciumIBA 08/2017 - 10/2011
2	rho-Associated KinasesIBA 06/2014 - 01/2013
2	Diltiazem (Cardizem)FDA LinkGeneric 03/2014 - 12/2013
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 12/2013 - 04/2005
2	Ramipril (Altace)FDA LinkGeneric 01/2013 - 08/2010
2	Endothelin-1 (Endothelin 1)IBA 06/2011 - 12/2004
2	Apolipoproteins E (ApoE)IBA 05/2010 - 11/2006
2	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2006 - 07/2006
2	Endothelins (Endothelin)IBA 06/2006 - 12/2004
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2022
1	Cyclooxygenase InhibitorsIBA 01/2022
1	SodiumIBA 01/2022
1	Taurine FDA Link 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2022
1	SaltsIBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Pentaerythritol Tetranitrate (Pentalog)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Complementary DNA (cDNA)IBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021

Therapy/Procedure

10	Ligation 12/2019 - 10/2008
6	Therapeutics 01/2021 - 07/2012
2	Punctures 01/2019 - 12/2014
2	Nephrectomy 01/2013 - 08/2012